Summary

10.42 1.42(15.73%)10/15/2024
Walgreens Boots Alliance Inc (WBA)

Key Facts


1 Day1 Week1 Month3 Months6 Months1 Year5 YearsAll Time
15.8114.7015.59-11.02-40.97-54.28-78.689,020.92


Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1


Trading Data
Close10.42
Open9.60
High10.64
Low9.60
Volume83,596,031
Change1.42
Change %15.81
Avg Volume (20 Days)21,409,567
Volume/Avg Volume (20 Days) Ratio3.90
52 Week Range8.25 - 27.05
Price vs 52 Week High-61.50%
Price vs 52 Week Low26.24%
Range8.49
Gap Up/Down0.15
Fundamentals
Market Capitalization (Mln)7,355
EBIDTA5,352,999,936
PE Ratio16.8155
PEG Ratio12.0008
WallStreet Target Price52.97
Book Value27.0620
Earnings Per Share2.9330
EPS Estimate Current Quarter1.0100
EPS Estimate Next Quarter0.0000
EPS Estimate Current Year4.7500
EPS Estimate Next Year5.0500
Diluted EPS (TTM)2.9330
Revenues
Profit Marging0.0192
Operating Marging (TTM)0.0277
Return on asset (TTM)0.0272
Return on equity (TTM)0.0864
Revenue TTM132,508,999,680
Revenue per share TTM153.2250
Quarterly Revenue Growth (YOY)0.1280
Quarterly Earnings Growth (YOY)0.6790
Gross Profit (TTM)28,067,000,000
Dividends
Dividend Share1.8800
Dividend Yield0.0383
Valuations
Trailing PE16.8155
Forward PE10.0908
Price Sales (TTM)0.0000
Price Book (MRQ)1.8261
Revenue Enterprise Value 0.5657
EBITDA Enterprise Value15.3838
Shares
Shares Outstanding863,945,024
Shares Float716,077,823
Shares Short0
Shares Short (Prior Month)0
Shares Ratio0.00
Short Outstanding (%)0.00
Short Float (%)0.00
Insider (%)17.29
Institutions (%)58.12


10/15 16:32 EST - seekingalpha.com
Walgreens: A Turnaround Stock To Avoid
Walgreens plans to close 1,200 stores, impacting 13.79% of its total locations, to restructure and improve financial health. Despite beating Wall Street estimates, Walgreens' adjusted operating income fell 38%, and adjusted EPS dropped to $0.39 from $0.67 a year ago. The company's financials have been weak, with negative free cash flow and inconsistent performance, making it a risky investment.
10/15 12:38 EST - seekingalpha.com
Walgreens Boots Alliance, Inc. (WBA) Q4 2024 Earnings Call Transcript
Walgreens Boots Alliance, Inc. (NASDAQ:WBA ) Q4 2024 Earnings Call Transcript October 15, 2024 8:30 AM ET Company Participants Tiffany Kanaga - VP of Global IR Tim Wentworth - CEO Manmohan Mahajan - Global CFO Mary Langowski - President, US Healthcare Conference Call Participants Lisa Gill - JPMorgan Ann Hynes - Mizuho Group George Hill - Deutsche Bank Charles Rhyee - TD Securities Eric Percher - Nephron Research Kevin Caliendo - UBS Elizabeth Anderson - Evercore ISI Michael Cherny - Leerink Partners Stephanie Davis - Barclays Operator Good day, ladies and gentlemen. Thank you for standing by.
10/15 12:25 EST - zacks.com
WBA Stock Up on Q4 Earnings & Revenues Beat, Unveils Strategic Action
Walgreens reports better-than-expected earnings and revenues in the fourth quarter of fiscal 2024.
10/15 12:07 EST - pymnts.com
Walgreens Doesn't ‘Count on' Strong Consumer Spend for Q4
Walgreens Boots Alliance is undertaking a transformation focused on its retail pharmacy business in response to persistent challenges in the consumer market and pharmacy sector. As part of this strategy, the company plans to close approximately 1,200 underperforming stores in the next three years to streamline operations and increase profitability.
10/15 11:51 EST - fool.com
Why Walgreens Boots Alliance Stock Is Skyrocketing Today
Investors are applauding the pharmacy retailer's plan to close many of its unprofitable stores.
10/15 10:42 EST - forbes.com
Walgreens Closing 1,200 Stores As Earnings Beat Projections
Walgreens will close 1,200 stores over the next three years after announcing fourth-quarter earnings on Tuesday that beat analyst expectations, as the pharmacy chain—which reported future “significant” store closures earlier this year—works to free up its cash flow.
10/15 10:39 EST - proactiveinvestors.com
Walgreen Boots Alliance plans to close 1,200 stores as annual losses double
Walgreens Boots Alliance Inc (NASDAQ:WBA, ETR:W8A) was one of the top risers on the S&P 500, jumping 10.4% as it announced plans to close most of its underperforming stores.  Investors were impressed by news that the drug store chain plans to close around 1,200 of its 8,700 US drugstores over the next three years, saying a quarter of its outlets are unprofitable.
10/15 10:31 EST - zacks.com
Compared to Estimates, Walgreens (WBA) Q4 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Walgreens (WBA) give a sense of how the business performed in the quarter ended August 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
10/15 09:31 EST - investopedia.com
Walgreens Plans To Close 1,200 Stores Over Next Three Years
Walgreens Boots Alliance (WBA) said Tuesday that it is shutting around 1,200 stores over the next three years, as the drugstore chain moves to turn around its troubled U.S. business.
10/15 09:30 EST - invezz.com
Walgreens to close 1,200 stores as CEO Wentworth drives turnaround strategy
Walgreens Boots Alliance has announced plans to shutter 1,200 stores across the US over the next three years as the company embarks on a comprehensive turnaround strategy under new CEO Tim Wentworth.
10/15 09:11 EST - zacks.com
Walgreens Boots Alliance (WBA) Surpasses Q4 Earnings and Revenue Estimates
Walgreens Boots Alliance (WBA) came out with quarterly earnings of $0.39 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.67 per share a year ago.
10/15 08:51 EST - foxbusiness.com
Walgreens to close 1,200 stores as part of turnaround effort
Walgreens announced that it will close about 1,200 stores over the next three years, with 500 shuttering as early as next year. It's part of the company's turnaround effort.
10/15 08:41 EST - nypost.com
Walgreens to close 1,200 stores nationwide, says 1 in 4 locations are unprofitable
Walgreens announced that it will shutter 1,200 stores over the next three years — and 500 locations in 2025 alone — as the drugstore giant seeks to slash $1 billion in costs.
10/15 08:31 EST - marketbeat.com
Big Potential Brewing – Will Walgreens Deliver a Rally?
Every once in a while, a major brand name and its stock's existence are challenged. Often, the price action and the threatening state of the company are justified, and the business does end up going under.
10/15 08:19 EST - marketwatch.com
Walgreens plans to close 1,200 stores as it looks for a turnaround
Walgreens' stock has been hammered this year as consumer shopping patterns have changed, but the company's latest earnings are getting better reception.
10/15 08:14 EST - investors.com
Walgreens Stock Jumps As Ailing Drug Store Giant Plans To Cut 1,200 Locations
Walgreens topped Q4 estimates and announced plans to close 1,200 drug store locations, including 500 in fiscal 2025. Shares jumped.
10/15 07:24 EST - businessinsider.com
Walgreens is closing 1,200 stores
Walgreens to close about 1,200 stores in the US over the next three years. The closures follow a June announcement to shut 25% of its US locations.
10/15 07:06 EST - cnbc.com
Walgreens says it will close 1,200 stores by 2027, as earnings top estimates
Walgreens reported fiscal fourth-quarter sales and profit that beat Wall Street's expectations, reflecting the company's efforts to slash costs. The retail drugstore chain also said it plans to close roughly 1,200 stores over the next three years, which includes 500 closures in fiscal 2025 alone.
10/15 07:05 EST - forbes.com
Walgreens Loses Another $3 Billion And Plans To Close 1,200 Stores
On a day when Walgreens Boots Alliance reported another $3 billion in losses, the drugstore chain said it will close 1,200 stores over three years in an effort to return to profitability and long-term growth.
10/15 07:02 EST - reuters.com
Walgreens to shutter 1,200 stores as CEO Wentworth seeks turnaround
Walgreens Boots Alliance said on Tuesday it would shut 1,200 stores over the next three years as new CEO Tim Wentworth plots a turnaround at the struggling pharmacy chain operator hit by sluggish consumer spending and low drug reimbursement rates.